Raymond Tabibiazar biography
Dr. Raymond Tabibiazar M.D. serves as Independent Director of the Company. Dr. Tabibiazar is Private Aravive’s founder and served as the Chairman of Private Aravive’s board of directors and as Private Aravive’s President and Chief Executive Officer from its inception in 2007 to April 2017 and as Executive Chairman since May 2017. In addition to his role at Private Aravive, since April 2010 Dr. Tabibiazar also is the Managing Director of 525 Ventures, a life sciences strategic consulting company working with both public and private biopharmaceutical firms. Dr. Tabibiazar also served from October 2018 until April 2019 as Senior Vice President of Twist Bioscience, Inc., a Nasdaq-listed public company that manufactures synthetic DNA for clients in the biotechnology industry and from January 2016 until October 2018 as an advisor to Twist Bioscience, Inc. Prior to founding Private Aravive, Dr. Tabibiazar was a Venture Partner at Bay City Capital LLC, a large venture capital firm in the Bay Area. Prior to that, Dr. Tabibiazar served as the Chief Scientific Officer of Aviir, Inc., a molecular diagnostic company, as well as Vice President of Translational Research of VIA Pharmaceuticals, Inc., a cardiometabolic therapeutic company. Before moving to industry, Dr. Tabibiazar was a practicing cardiologist and an adjunct clinical instructor in medicine at Stanford University. Dr. Tabibiazar received his medical degree from Harvard Medical School and trained as an internist and cardiologist at Stanford University, while also receiving finance education at Stanford Business School. Dr. Tabibiazar received board certifications in Internal Medicine, Cardiovascular Medicine, Nuclear Medicine, and Cardiovascular Imaging.
What is the salary of Raymond Tabibiazar?
As the Independent Director of Aravive Inc, the total compensation of Raymond Tabibiazar at Aravive Inc is $119,679. There are 5 executives at Aravive Inc getting paid more, with Gail McIntyre having the highest compensation of $713,495.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
How old is Raymond Tabibiazar?
Raymond Tabibiazar is 49, he's been the Independent Director of Aravive Inc since 2018. There are 8 older and 2 younger executives at Aravive Inc. The oldest executive at Aravive Inc is Fredric Eshelman, 72, who is the Independent Chairman of the Board.
What's Raymond Tabibiazar's mailing address?
Raymond's mailing address filed with the SEC is C/O ARAVIVE, INC., 3730 KIRBY DRIVE, SUITE 1200, HOUSTON, TX, 77098.
Insiders trading at Aravive Inc
Over the last 6 years, insiders at Aravive Inc have traded over $107,045 worth of Aravive Inc stock and bought 151,333 units worth $1,102,898 . The most active insiders traders include Srinivas Akkaraju, Fredric N Eshelman Ventures..., eShahzad Malik. On average, Aravive Inc executives and independent directors trade stock every 75 days with the average trade being worth of $11,962. The most recent stock trade was executed by Fredric N Eshelman Ventures... on 1 April 2022, trading 4,545,455 units of ARAV stock currently worth $181,818.
What does Aravive Inc do?
versartis, inc. (nasdaq: vsar) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. the company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. versartis’ mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. learn more at www.versartis.com.
What does Aravive Inc's logo look like?
Aravive Inc executives and stock owners
Aravive Inc executives and other stock owners filed with the SEC include:
-
Gail McIntyre,
President, Chief Executive Officer, Director -
Vinay Shah,
Chief Financial Officer -
Dr. Gail F. McIntyre CH (ASCP), DABT, Ph.D.,
Pres, CEO & Director -
Dr. Reshma Rangwala M.D., Ph.D.,
Chief Medical Officer -
Amato Giaccia,
Independent Director -
Raymond Tabibiazar,
Independent Director -
Eric Zhang,
Independent Director -
Dr. Fredric N. Eshelman Pharm.D.,
Exec. Chairman -
Mike Zanoni,
IR Contact Officer -
Michael Rogers,
Director -
Reshma Rangwala,
Chief Medical Officer -
Fredric Eshelman,
Independent Chairman of the Board -
Kenneth L. Guernsey,
Sec. -
Dr. Randy L. Anderson,
Sr. VP of Data Sciences -
Joseph T. Schepers,
VP of Investor Relations -
Dr. Joshua Silverman Ph.D.,
Co-Founder -
Dr. Jeffrey L. Cleland,
Co-Founder -
Maria Carolina Petrini,
Chief Commercial Officer -
Robert B. Geller,
Chief Medical Officer -
Leonard Scott Dove,
Chief Operating Officer -
Rekha Hemrajani,
-
Srinivas Akkaraju,
Director -
Jay Shepard,
President and CEO -
Kevin Haas,
VP, Finance and PAO -
Shahzad Malik,
Director -
Robert Hoffman,
Director -
Peter Tai Ching Ho,
Director -
John Hohneker,
Director -
Sigurd Kirk,
Director -
Rudy Howard,
Chief Financial Officer